Oral GLP-1
Oral GLP-1 Analogue
|
Primary Indication |
Treatment of Type 2 diabetes mellitus |
|
Stage of Development
|
Entering Phase I/IIa |
- Outlicensing opportunity - providing oral formulation technology to GLP-1 analogue
- Stimulates insulin formation and release when blood glucose levels are high
- Reduces glucose output from the liver
- Improves insulin sensitivity and the function of ß-cells
- Slows emptying of stomach and reduces desire to eat
Print 